Koch, Inc. Discloses Investment at Ibotta with 20.7% Stake
Koch, Inc. has publicly announced a 20.7% stake in Ibotta, Inc.'s Class A common stock, filing a Schedule 13D after previously holding a Schedule 13G. This change reflects a higher percentage due to a decrease in outstanding Class A shares, not an increase in Koch's holdings, and the company maintains it is a "passive investor" with less than 10% of Ibotta’s total voting power. Koch, a privately held conglomerate, invests for long-term support of management teams rather than seeking to influence control.
APR 2·Stock Titan▲
Koch affiliates report 20.7% Ibotta (NYSE: IBTA) Class A stake
Koch, Inc. and its affiliates have reported a beneficial ownership of 4,389,129 Class A common shares of Ibotta, Inc. (NYSE: IBTA), representing approximately 20.7% of the Public Shares outstanding. This significant stake arose from the reclassification of pre-IPO securities and a reduction in outstanding shares due to Ibotta's stock repurchases. The Koch group identifies as passive investors, acknowledging that Ibotta's CEO and related parties maintain majority voting control through Class B shares.
JAN 19·GlobeNewswire→
Attention Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of Ibotta, Inc., Lifecore Biomedical, Inc., Molina Healthcare, Inc., and WEBTOON Entertainment Inc. The law office is encouraging long-term shareholders of these companies, who purchased shares during specific periods, to contact them to seek corporate reforms and other remedies at no cost. The investigations stem from alleged misleading statements, internal control deficiencies, and other issues that affected the companies' financial projections and investor information.
